Pegaptanib is used in the treatment of wet form of age-related macular degeneration
How it works
Pegaptanib is a monoclonal antibody, used to treat several eye diseases causing vision impairment. It works by stopping abnormal blood vessel growth and leakage in the eye(s) that occur due to excess human vascular endothelial growth factor A (VEGF-A), thereby preventing from vision loss.
Common side effects
Foreign body sensation in eyes, Increased intraocular pressure, Eye pain, Punctate keratitis, Eye floaters, Visual disturbance, Cataract, Blurred vision, Eye inflammation, Stinging in the eyes, Increased blood pressure, Corneal edema, Eye itching, Conjunctival hemorrhage, Visual impairment, Burning sensation in eye, Eye discharge
- ₹44571Pfizer Ltd1 variant(s)
- Consult your ophthalmologist immediately if the eye becomes red, sensitive to light, painful or develops a change in vision.
- Patients should not drive or use machines immediately after receiving pegaptanib intravitreal injection which may influence the driving ability.
- Before taking pegaptanib, inform you doctor if you are pregnant, planning a pregnancy or breast-feeding.
Frequently asked questions
Q. What is pegaptanib sodium?
Pegaptanib injection belongs to a class of medications called vascular endothelial growth factor (VEGF) antagonists. Pegaptanib is mainly used for the treatment of exudative (wet) neovascular age-related macular degeneration (AMD, a disease of the eye that affects vision).